Fractyl Health, Inc. (GUTS)
0.60
+0.01
(+1.56%)
USD |
NASDAQ |
Sep 18, 16:00
0.5917
-0.01
(-1.38%)
After-Hours: 20:00
Fractyl Health Enterprise Value : 108.79M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 108.79M |
| September 17, 2026 | 107.33M |
| September 16, 2026 | 102.84M |
| September 15, 2026 | 103.23M |
| September 14, 2026 | 110.63M |
| September 11, 2026 | 115.13M |
| September 10, 2026 | 115.62M |
| September 09, 2026 | 115.13M |
| September 08, 2026 | 122.30M |
| September 04, 2026 | 124.11M |
| September 03, 2026 | 122.64M |
| September 02, 2026 | 125.71M |
| September 01, 2026 | 125.94M |
| August 31, 2026 | 126.36M |
| August 28, 2026 | 118.15M |
| August 27, 2026 | 131.28M |
| August 26, 2026 | 130.54M |
| August 25, 2026 | 137.95M |
| August 24, 2026 | 132.58M |
| August 21, 2026 | 137.34M |
| August 20, 2026 | 122.29M |
| August 19, 2026 | 122.43M |
| August 18, 2026 | 127.36M |
| August 17, 2026 | 118.30M |
| August 14, 2026 | 121.48M |
| Date | Value |
|---|---|
| August 13, 2026 | 118.62M |
| August 12, 2026 | 124.02M |
| August 11, 2026 | 124.94M |
| August 10, 2026 | 120.68M |
| August 07, 2026 | 124.59M |
| August 06, 2026 | 122.59M |
| August 05, 2026 | 122.27M |
| August 04, 2026 | 122.27M |
| August 03, 2026 | 121.03M |
| July 31, 2026 | 122.27M |
| July 30, 2026 | 123.06M |
| July 29, 2026 | 123.06M |
| July 28, 2026 | 128.24M |
| July 27, 2026 | 140.67M |
| July 24, 2026 | 136.23M |
| July 23, 2026 | 133.65M |
| July 22, 2026 | 133.85M |
| July 21, 2026 | 135.91M |
| July 20, 2026 | 137.47M |
| July 17, 2026 | 142.10M |
| July 16, 2026 | 149.13M |
| July 15, 2026 | 157.97M |
| July 14, 2026 | 140.52M |
| July 13, 2026 | 134.44M |
| July 10, 2026 | 139.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 2.764M |
| Spectral AI, Inc. | 55.06M |
| Vaxcyte, Inc. | 7.045B |
| Moderna, Inc. | 57.61B |
| Arrowhead Pharmaceuticals, Inc. | 9.157B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.54M |
| Total Expenses (Quarterly) | 25.54M |
| EPS Diluted (Quarterly) | -0.161 |
| Earnings Yield | -182.2% |
| Normalized Earnings Yield | -141.18 |